Related references
Note: Only part of the references are listed.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting
Derek T. Hall et al.
EMBO MOLECULAR MEDICINE (2018)
Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet
Garima Singhal et al.
MOLECULAR METABOLISM (2018)
FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21-SIRT1-AMPK-PGC1α Pathway
Xinyi Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Inflammation and age-associated skeletal muscle deterioration (sarcopaenia)
Jinyu Wang et al.
JOURNAL OF ORTHOPAEDIC TRANSLATION (2017)
Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle
Margaret Chui Ling Tse et al.
DIABETES (2017)
Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis
Alexander Kalinkovich et al.
AGEING RESEARCH REVIEWS (2017)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
AMPK Activation of Muscle Autophagy Prevents Fasting-Induced Hypoglycemia and Myopathy during Aging
Adam L. Bujak et al.
CELL METABOLISM (2015)
Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice
W. Y. So et al.
CELL DEATH & DISEASE (2015)
Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine
Susanne Keipert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes
Dong-Tao Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation
M. Straczkowski et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death
Jaeseok Han et al.
NATURE CELL BIOLOGY (2013)
Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
Kook Hwan Kim et al.
NATURE MEDICINE (2013)
AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm
Marion Pauly et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
Matthew J. Potthoff et al.
GENES & DEVELOPMENT (2012)
ER stress-induced inflammation: does it aid or impede disease progression?
Abhishek D. Garg et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes
Balindiwe J. N. Sishi et al.
CYTOKINE (2011)
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
Sandra Galic et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III
Preethi Srikanthan et al.
PLOS ONE (2010)
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
R. J. Shaw
ACTA PHYSIOLOGICA (2009)
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models-association with liver and adipose tissue effects
Jing Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Positive and negative signaling components involved in TNF alpha-induced NF-kappa B activation
Hongxiu Li et al.
CYTOKINE (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
FGF21 is an Akt-regulated myokine
Yasuhiro Izumiya et al.
FEBS LETTERS (2008)
AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes
Kazuki Nakashima et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2007)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
SH Lecker et al.
FASEB JOURNAL (2004)
Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle
CJ Wray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Share Paper
